Amedica Corporation s in-depth stock price analysis indicates that the stock price has dropped -51.89% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -59.51% . Looking at the past 52 week period, the stock price is down -80.71% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Amedica Corporation has a negative value of -59.34 compared to overall market performance. Stocks of Amedica Corporation (NASDAQ:AMDA) rallied by 7.6% during the past week but lost 39.42% on a 4-week basis. The company has outperformed the S&P 500 by 6.74% in the past week but underperformed the index by 40.5% in the last 4 weeks.
Amedica Corporation (NASDAQ:AMDA) : On Friday heightened volatility was witnessed in Amedica Corporation (NASDAQ:AMDA) which led to swings in the share price. The stock opened for trading at $0.395 and hit $0.42 on the upside , eventually ending the session at $0.409, with a gain of 3.54% or 0.014 points. The heightened volatility saw the trading volume jump to 1,227,449 shares. The 52-week high of the share price is $3.23 and the company has a market cap of $15 million. The 52-week low of the share price is at $0.3537 .
Company has reported several Insider transactions to the SEC, on Dec 11, 2015, David W. Truetzel (director) sold 20,625 shares at 0.00 per share price.On Sep 14, 2015, Ty Lombardi (VP Finance) purchased 25,000 shares at 0.40 per share price.
Amedica Corporation is a commercial biomaterial company. It is focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company market spinal fusion products and are developing products for use in total hip and knee joint replacements. Amedica Corporation is based in Salt Lake City, Utah.